Bath & Body Works, Inc. BBWI

16.45 (0.35) (2.08%) as of 25 Sep
Market cap
$3.4B
P/E
4.3×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Insider Decisions

Total buys 1.01
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — 6 — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 1.09%

Capital & Financial Ratios

Market Cap 3,410.00
Revenue 7,210.00
Net Income 781.00
Free Cash Flow 1,048.00
Net Debt 2,820.00
Current Ratio 1.20
Debt/Equity (3.43)
P/E ratio 4.28
P/S ratio 0.46
P/B ratio 0.00
Past 5Y EPS Growth 3.75%
This Y EPS Growth (15.60%)
Next Y EPS Growth 2.08%
Next 5Y EPS Growth (2.89%)
in millions of $

Dividends

Payout Ratio 0.26
Annual Dividend Rate 0.80
Annual Dividend Yield 1.84%
total individual payouts
2029 Powerpack
2028 Powerpack
2027 Powerpack
2026 0.80
0.20
0.20
0.20
2025 0.80
0.20
0.20
0.20
0.20
2024 0.80
0.20
0.20
0.20
0.20
2023 0.80
0.20
0.20
0.20
0.20
2022 0.80
0.20
0.20
0.20
0.20
2021 0.42
0.12
0.15
0.15
2020 0.24
0.24
2019 0.97
0.24
0.24
0.24
0.24
2018 1.94
0.49
0.49
0.49
0.49
2017 2.54
0.49
0.49
0.60
0.49
0.49
2016 1.46
1.62
0.49
0.49
0.49
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2024 2025 2026 Q'26
Cash 1,084 674 953 794
Receivables 224 205 180 154
Inventory 710 734 699 883
Other 97 210 187 219
2,115 1,823 2,019 2,050
2024 2025 2026 Q'26
Payables 380 338 465 676
ST’ Debt — — 280 248
Other — — — —
1,289 1,231 1,591 1,707
in millions of $

Compound Annual Growth

10y 5y 3y
Sales (4.98%) 2.53% (1.20%)
Cash Flow (5.91%) (11.58%) (1.24%)
Earnings (6.37%) (5.12%) (6.74%)
Book Value 0.00% 0.00% 0.00%

Revenue

Apr Jul Oct Jan Year
’26 1,378 1,514 — — —
’26 1,424 1,549 1,594 2,724 7,291
’25 1,384 1,526 1,610 2,787 7,307
’24 1,396 1,559 1,562 2,912 7,429
’23 1,450 1,618 1,604 2,888 7,560
’22 1,470 1,704 1,681 3,027 7,882
’21 1,654 2,319 1,702 2,718 6,434
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Apr Jul Oct Jan Year
’26 244 72 — — —
’26 188 (43) 80 877 1,102
’25 76 (46) (99) 955 886
’24 44 33 (49) 926 954
’23 66 15 (14) 1,077 1,144
’22 249 324 (126) 1,045 1,492
’21 (342) 628 420 1,333 2,039
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Apr Jul Oct Jan Year
’26 203 23 — — —
’26 151 (99) 8 814 874
’25 30 (101) (164) 895 660
’24 (49) (52) (121) 878 656
’23 (22) (58) (105) 1,001 816
’22 184 211 (189) 1,016 1,222
’21 (397) 559 344 1,305 1,811
in millions of $ · fiscal quarters ending in the months shown

EPS

Apr Jul Oct Jan Year
’26 0.90 0.58 — — —
’26 0.49 0.30 0.37 1.99 3.11
’25 0.38 0.68 0.49 2.09 3.61
’24 0.35 0.43 0.52 2.55 3.84
’23 0.64 0.52 0.40 1.89 3.43
’22 0.97 1.34 0.33 2.28 4.88
’21 (1.07) (0.18) 1.17 3.03 3.00
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

2.5
1Buy 2 3Hold 4 5Sell
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029
28.29 19.17 12.77 6.47 29.18 25.75 27.30 26.21 14.28 15.74

Analyst estimates 2027–2029

Powerpack
Low Price
55.33 49.67 24.00 34.09 82.00 71.51 49.55 52.99 41.87 24.94
High Price
93,600 93,200 88,900 94,400 92,300 56,900 57,200 57,157 59,210 60,735
Employees
0 0 0 0 0 0 0 0 0 0
Revenue/Emp
12,574 12,632 13,237 5,405 6,434 7,882 7,560 7,429 7,307 7,291
Revenue
40.76% 39.26% 37.01% 44.16% 48.12% 48.91% 43.06% 43.56% 44.26% 43.74%
Gross Margin
1,696 1,312 857 608 1,122 1,423 1,045 1,021 1,028 882
EBT
13.49% 10.39% 6.47% 11.25% 17.44% 18.05% 13.82% 13.74% 14.07% 12.10%
EBT Margin
1,158 983 644 (366) 844 1,333 800 878 798 649
Net Income
472 524 547 1,308 521 363 221 269 282 254
Depreciation
43.81 44.48 47.96 19.58 23.14 29.30 32.59 32.58 33.21 35.05
Revenue/Sh
3.98 3.42 2.31 (1.33) 3.00 4.88 3.43 3.84 3.61 3.11
Earnings/Sh
6.93 4.95 4.99 4.48 7.33 5.55 4.93 4.18 4.03 5.30
Cash Flow/Sh
(3.26) (2.49) (2.28) (1.66) (0.82) (1.00) (1.41) (1.31) (1.03) (1.10)
Capex/Sh
3.67 2.46 2.71 2.82 6.51 4.54 3.52 2.88 3.00 4.20
Free CF/Sh
(2.53) (2.64) (3.13) (5.42) (2.38) (5.64) (9.50) (7.13) (6.29) (6.15)
Book Value/Sh
287 284 276 276 278 269 232 228 220 208
Shares
12.20 11.77 9.74 0.00 11.47 10.74 13.34 11.08 10.33 7.06
PE Ratio
1.11 0.91 0.47 0.40 1.14 1.55 1.41 1.31 1.13 0.63
PS Ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PB Ratio
1.41 1.25 0.80 0.71 1.55 1.88 1.92 1.78 1.61 1.04
EV/Sales
16.88 22.57 14.19 11.86 7.18 14.45 17.75 20.16 17.88 8.66
EV/FCF
1,990 1,406 1,377 1,236 2,039 1,492 1,144 954 886 1,102
Op' Cash Flow
(937) (707) (629) (458) (228) (270) (328) (298) (226) (228)
Capex
1,053 699 748 778 1,811 1,222 816 656 660 874
FCF
1,451 1,262 1,274 873 2,753 1,719 887 826 592 428
Working Cap'
5,736 5,794 5,811 5,548 6,539 5,024 5,039 4,388 3,884 3,892
Total Debt
3,802 4,279 4,398 4,049 2,971 3,045 3,807 3,304 3,210 2,939
Net Debt
(727) (751) (865) (1,495) (661) (1,517) (2,205) (1,626) (1,383) (1,279)
Sh' Equity
13.90% 12.05% 7.93% (4.02%) 7.78% 15.15% 13.89% 16.03% 15.44% 13.06%
ROA
40.71% 30.61% 21.88% 25.45% 43.40% 82.17% 53.68% 47.86% 43.31% 42.39%
ROIC
(235.13%) (133.02%) (79.70%) 31.02% (78.29%) (122.41%) (42.99%) (45.84%) (53.04%) (48.76%)
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Jan 2026 · latest quarter Jul 2026

Bath & Body Works, Inc. (BBWI) key facts

  • Bath & Body Works, Inc. (BBWI) is a Specialty Retail company in the Consumer Cyclical sector, listed on the New York Stock Exchange.
  • Bath & Body Works, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $7.3 billion, roughly unchanged from fiscal 2025.
  • Net income was $649.0 million, or $3.11 per share (basic), a net margin of 8.90%.
  • As of September 25, 2026, BBWI traded at $16.45, a market capitalization of $3.4 billion.
  • At that price the stock trades at 4.3× trailing-twelve-month earnings and 0.5× sales.
  • Bath & Body Works, Inc. pays an annual dividend of $0.80 per share, a yield of 1.84%, with a payout ratio of 26.5%.
  • Return on equity was −48.8% and debt-to-equity -3.43.

Source: company filings (standardised) and stockrow calculations.

Bath & Body Works, Inc. (BBWI) Latest News

News by impact score

Fine-tune

25 Sep

4

Bath & Body Works reported a strong Q2 FY2026 beat with adjusted EPS of $0.62 (up 67.6% YoY) on net sales of $1.514B, down 2.3% but above consensus. Tariff refunds of about $80M boosted margins, while direct-to-consumer and international growth supported results. U.S./Canada store sales fell 5.4% to $1.13B; direct sales rose 3% to $275M; international sales jumped 24.9% to $108M. Gross profit rose 8.1% to $692M, margin 45.7% aided by refunds; ex-refund margin ~40.4%. SG&A flat at $467M; adjusted op. income up 30.4% to $225M (margin 14.8%). Cash, inventories, and debt improved; year-to-date cash flow stronger. Q3 guidance calls for sales down 5%-2.5% and EPS of 7-12c (GAAP 5-10c). Full-year outlook raised: net sales down 4%-2.5%; adjusted EPS $2.60-$2.80; GAAP $3.13-$3.33; FCF ~ $650M; capex ~$240M. Shares down ~9.9% since last report; consensus estimate revisions moved sharply lower. Widespread downward revisions to estimates despite a quarterly beat and raised full-year outlook indicate meaningful investor sentiment risk and a potentially slower near-term trajectory.

10 Sep

4

Bath & Body Works shares rise in extended trading after Barington Capital urges the company to explore a sale. Activist demand for a sale signals potential acquisition or major strategic overhaul that can significantly shift company trajectory and investor sentiment.

28 Aug

3

Bath & Body Works returned to digital growth yet projects overall sales decline, leaving uncertainty whether e-commerce gains can offset persistently weak store traffic. Expected sales decline combined with partial digital recovery indicates moderate pressure on near-term performance without altering long-term trajectory.

3

Bath & Body Works launches Reserve Collection for home fragrance products. New product collection in core home fragrance category supports incremental sales and innovation positioning.

27 Aug

4

Bath & Body Works stock rose 7.5% after beating Q2 earnings expectations and raising its fiscal 2026 outlook. Earnings beat combined with raised 2026 guidance signals stronger financial results and positive investor sentiment for BBWI.

4

Bath & Body Works advances digital revamp and new distribution initiatives in Q2 while facing tariff pressures. Digital revamp and new distribution initiatives represent major strategic moves that could significantly alter trajectory despite tariff headwinds.

3

Bath & Body Works Q2 net sales decline due to weak underlying demand. Q2 sales drop signals demand weakness that may pressure near-term revenue and valuation.

3

Bath & Body Works e-commerce returns to growth. E-commerce growth resumption indicates potential revenue gains for Bath & Body Works.

26 Aug

4 transcript

Bath & Body Works Inc beat Q2 2026 earnings guidance and raised its outlook. Beating guidance and raising outlook signals stronger financial results with direct positive effects on stock valuation and future projections.

4 transcript

BBWI held its Q2 2027 earnings call, covering financial results, operations and forward outlook. Earnings call details directly shape near-term stock movement and valuation.

4

Bath & Body Works raised its earnings outlook after beating second-quarter estimates, driving shares higher. Earnings beat plus raised outlook signals stronger performance and lifts investor sentiment.

4

Bath & Body Works raised its full-year earnings outlook after second-quarter profits exceeded forecasts. Profit beat combined with raised full-year guidance points to stronger future financial results and positive market reaction.

4

Bath & Body Works raised its annual outlook after beating Q2 profit forecasts. Profit beat combined with raised annual guidance signals stronger financial results and improved market positioning.

3

Bath & Body Works Q2 earnings key metrics detail revenue, margins and comparable sales trends that shape views on retail performance and outlook. Q2 earnings metrics supply financial data that can shift near-term investor sentiment and valuation without altering long-term strategy.

3 transcript

Bath & Body Works, Inc. held its Q2 2027 earnings call, covering financial results, operational updates and forward guidance for the company. Quarterly earnings data typically offers moderate insight into performance and outlook without signaling major strategic shifts.

3

Bath & Body Works shares rise sharply after the company posts stronger-than-expected quarterly sales and raises full-year guidance, reflecting improved store traffic and online demand. Better sales and raised guidance can moderately lift near-term financial results and sentiment without reshaping long-term strategy.

3

Bath & Body Works beat Q2 Wall Street sales estimates yet continues facing insufficient consumer store traffic. Q2 sales beat signals short-term resilience while ongoing traffic shortfalls point to sustained pressure on future revenue growth.

3

Bath & Body Works stock climbs after beating earnings expectations, though forward guidance is mixed. Earnings beat supports near-term stock gains while mixed guidance caps broader trajectory shifts.

3 transcript

Bath & Body Works Q2 earnings call highlighted comparable sales trends, gross margin expansion, and updated full-year guidance amid ongoing consumer spending caution. Q2 earnings call updates on sales, margins, and guidance can moderately shift near-term investor sentiment and valuation.

3

Bath & Body Works raised its profit outlook for Q2 2026 but reported weak sales. Mixed earnings signals with higher profit guidance offset by weak sales point to moderate effects on near-term investor views and operations.

3

Bath & Body Works beat earnings expectations but forecasts lower third-quarter earnings. Earnings beat offers short-term positive signal while lower third-quarter guidance introduces caution on near-term results.

3

Bath & Body Works (BBWI) posted Q2 earnings and revenues that exceeded analyst estimates. Q2 earnings and revenue beats deliver a positive but limited short-term lift to stock performance.

3

Bath & Body Works CEO states 2026 remains an investment year focused on long-term growth initiatives rather than immediate returns. CEO guidance labeling 2026 as investment year directly shapes earnings expectations and capital allocation outlook for the retailer.

3

Bath and Body Works beat Q2 CY2026 expectations but issued disappointing Q3 guidance. Mixed quarterly results with an earnings beat offset by weak forward guidance typically drive moderate short-term stock volatility.

3

Bath & Body Works reported second quarter results exceeding guidance along with continued progress on its transformation. Earnings beat and transformation updates point to noticeable but not transformative effects on financials and positioning.

24 Aug

4

BBWI set to report quarterly earnings with focus on comparable sales, margins, EPS and forward guidance amid ongoing retail sector pressures. Earnings data and guidance directly shape near-term stock trajectory and valuation for BBWI.

3

Bath & Body Works launches the Reserve Collection as a new home fragrance franchise. New fragrance franchise represents product innovation with moderate potential to influence sales and positioning.

18 Aug

4

Bath & Body Works pursues dividend payouts alongside Disney partnerships to strengthen brand moat and competitive positioning. Dividends combined with Disney deals represent major strategic moves capable of shifting brand trajectory and investor views.

3

Bath & Body Works shares rose after Citi upgraded the stock to Buy. Citi Buy upgrade triggered share price gains but represents limited fundamental change.

4 Aug

3

Bath & Body Works (BBWI) may beat earnings estimates in its next report, extending a pattern of positive surprises that could shape near-term investor sentiment and stock movement. Earnings preview questions create short-term sentiment shifts but lack major strategic or operational changes.

stockrow.com/BBWI · Data as of Jul 31, 2026 · For information only; not investment advice. · © 2026 stockrow.com